Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/33144
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-23T10:10:24Z | - |
dc.date.available | 2023-06-23T10:10:24Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Hartavi, M. vd. (2013). “The SOCS-1-1478CA/del polymorphism is not associated with colorectal cancer or age at onset in Turkish subjects”. Asian Pacific Journal of Cancer Prevention, 14(12), 7583-7586. | en_US |
dc.identifier.issn | 1513-7368 | - |
dc.identifier.uri | https://doi.org/10.7314/APJCP.2013.14.12.7583 | - |
dc.identifier.uri | http://koreascience.or.kr/article/JAKO201305981342565.page | - |
dc.identifier.uri | http://hdl.handle.net/11452/33144 | - |
dc.description.abstract | Background: Suppressor of cytokine signaling (SOCS)-1 acts as a key regulator of many cytokine signaling pathways and its abnormal expression has been identified in several human malignancies, suggesting potential roles in carcinogenesis. The aim of this study was to investigate any association between the functional SOCS-1 -1478CA>del polymorphism and colorectal cancer (CC) as well as age at onset in a Turkish clinical sample. Materials and Methods: A total of 122 subjects were enrolled in this case-control study (70 CC cases and 52 controls). The SOCS-1 -1478CA>del polymorphism was genotyped using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: The odds ratio of the del allele for CC relative to the CA allele was not significantly different between the groups (OR=0.71, 95% CI=0.41-1.22, p=0.27). This result did not change after adjustment for age and sex on multivariable regression analysis (OR=0.84, 95% CI=0.59-1.34, p=0.53). When the SOCS-1 -1478CA>del polymorphism was analyzed among CC patients in relation to the age at disease onset, we found no significant differences between subjects with the del/del, CA/del, and CA/CA genotypes. Conclusions: The results of our study did not point towards a major role of the SOCS-1 -1478CA>del polymorphism in the pathogenesis of CC in Turkish subjects. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Asian Pacific Organization Cancer Prevention | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Oncology | en_US |
dc.subject | Colorectal cancer | en_US |
dc.subject | Age at onset | en_US |
dc.subject | Suppressor of cytokine signaling | en_US |
dc.subject | Polymorphism | en_US |
dc.subject | Association study | en_US |
dc.subject | Tyrosine kinase | en_US |
dc.subject | Colon-cancer | en_US |
dc.subject | Risk-factors | en_US |
dc.subject | Ifn-gamma | en_US |
dc.subject | Suppressor | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Progression | en_US |
dc.subject | Methylation | en_US |
dc.subject | Carcinomas | en_US |
dc.subject | Adenomas | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Age of onset | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Colorectal neoplasms | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-up studies | en_US |
dc.subject.mesh | Gene deletion | en_US |
dc.subject.mesh | Genetic predisposition to disease | en_US |
dc.subject.mesh | Genotype | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Polymerase chain reaction | en_US |
dc.subject.mesh | Polymorphism, genetic | en_US |
dc.subject.mesh | Polymorphism, restriction fragment length | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Suppressor of cytokine signaling proteins | en_US |
dc.subject.mesh | Turkey | en_US |
dc.title | The SOCS-1-1478CA/del polymorphism is not associated with colorectal cancer or age at onset in Turkish subjects | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000331528900089 | tr_TR |
dc.identifier.scopus | 2-s2.0-84893384011 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Dahiliye Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İmmünoloji Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0003-0463-6818 | tr_TR |
dc.identifier.startpage | 7583 | tr_TR |
dc.identifier.endpage | 7586 | tr_TR |
dc.identifier.volume | 14 | tr_TR |
dc.identifier.issue | 12 | tr_TR |
dc.relation.journal | Asian Pacific Journal of Cancer Prevention | en_US |
dc.contributor.buuauthor | Hartavi, Mustafa | - |
dc.contributor.buuauthor | Kurt, Ender | - |
dc.contributor.buuauthor | Oral, Haluk Barbaros | - |
dc.contributor.buuauthor | Ölmez, Ömer Fatih | - |
dc.contributor.buuauthor | Çubukçu, Erdem | - |
dc.contributor.buuauthor | Deligönül, Adem | - |
dc.contributor.buuauthor | Avcı, Nilüfer | - |
dc.contributor.buuauthor | Manavoǧlu, Osman | - |
dc.contributor.researcherid | K-7285-2012 | tr_TR |
dc.identifier.pubmed | 24460337 | tr_TR |
dc.subject.wos | Oncology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 55370753300 | tr_TR |
dc.contributor.scopusid | 7006207332 | tr_TR |
dc.contributor.scopusid | 7004498001 | tr_TR |
dc.contributor.scopusid | 26435400000 | tr_TR |
dc.contributor.scopusid | 53986153800 | tr_TR |
dc.contributor.scopusid | 37088030300 | tr_TR |
dc.contributor.scopusid | 55390409800 | tr_TR |
dc.contributor.scopusid | 6602587152 | tr_TR |
dc.subject.scopus | Suppressor of Cytokine Signaling; Suppressors; Cytokines | en_US |
dc.subject.emtree | SOCS1 protein, human | en_US |
dc.subject.emtree | Suppressor of cytokine signaling | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Case control study | en_US |
dc.subject.emtree | Colorectal tumor | en_US |
dc.subject.emtree | Comparative study | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Gene deletion | en_US |
dc.subject.emtree | Genetic polymorphism | en_US |
dc.subject.emtree | Genetic predisposition | en_US |
dc.subject.emtree | Genetics | en_US |
dc.subject.emtree | Genotype | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Onset age | en_US |
dc.subject.emtree | Polymerase chain reaction | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Restriction fragment length polymorphism | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Hartavi_vd_2013.pdf | 507.2 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License